Brind.

Richard Griffiths holds the largest shareholder stake in Silence Therapeutics, according to reports from July 2025.

1 report, 0 independent Updated Jul 9

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Silence Therapeutics Richard Griffiths

Keep exploring

The entities involved

Silence Therapeutics
UK business
- Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.Wed 20:36
Richard Griffiths
British biological conservationist

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jul 9Unknown outlet